Literature DB >> 17534114

Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.

Suzanne C Dieudonné1, Ellen C La Heij, Roselie M H Diederen, Alfons G H Kessels, Albert T A Liem, Aize Kijlstra, Fred Hendrikse.   

Abstract

BACKGROUND: Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) are imbalanced in eyes with proliferative diabetic retinopathy or proliferative vitreoretinopathy (PVR). It is not known whether such an imbalance is already present in early PVR stages. We therefore analyzed VEGF and PEDF concentrations in subretinal fluids prior to PVR development.
METHODS: A large number (n = 137) of subretinal fluid samples were obtained at the time of scleral buckling surgery for rhegmatogenous retinal detachment (RRD). Thirty patients developed PVR within 6 months after surgery. One hundred and seven patients undergoing the same surgery but without complications served as controls. Furthermore, vitreous from 16 patients with macular hole or pucker (MHP) served as reference for baseline intraocular concentrations. PEDF and VEGF concentrations were measured by commercial ELISAs.
RESULTS: PEDF levels were substantially higher (9.6 microg/ml) compared to MHP vitreous (0.3 microg/ml, p < 0.001). VEGF levels were also higher (RRD: 0.07 ng/ml; MHP: 0.01 ng/ml, p < 0.05). Subretinal concentrations were not significantly different between PVR and control RRD patients.
CONCLUSIONS: Although both VEGF and PEDF are increased at first surgery for RRD, they do not predict PVR development later on. The high PEDF concentrations and its known antiangiogenic activity suggest a protective role against neovascularization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534114     DOI: 10.1159/000103234

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  14 in total

1.  Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.

Authors:  Steven Pennock; Andrius Kazlauskas
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

Review 2.  Proliferative Vitreoretinopathy: A Review.

Authors:  Sana Idrees; Jayanth Sridhar; Ajay E Kuriyan
Journal:  Int Ophthalmol Clin       Date:  2019

3.  Osteopontin expression in vitreous and proliferative retinal membranes of patients with proliferative vitreous retinopathy.

Authors:  Xiao-Yi Liu; Lei Li; Jia-Qi Yao; Xi Chen; Qing-Huai Liu
Journal:  Int J Ophthalmol       Date:  2011-08-18       Impact factor: 1.779

4.  Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

Authors:  Steven Pennock; David Kim; Shizuo Mukai; Matthew Kuhnle; Dal W Chun; Joanne Matsubara; Jing Cui; Patrick Ma; David Maberley; Arif Samad; Robert J Van Geest; Sarit L Oberstein; Reinier O Schlingemann; Andrius Kazlauskas
Journal:  Am J Pathol       Date:  2013-04-09       Impact factor: 4.307

5.  Protective effect of puerarin on diabetic retinopathy in rats.

Authors:  Yan Teng; Hao Cui; Mingming Yang; Han Song; Qingsheng Zhang; Ying Su; Jianqiu Zheng
Journal:  Mol Biol Rep       Date:  2008-06-28       Impact factor: 2.316

6.  Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Müller cells.

Authors:  Hua Mu; Xiao-Mei Zhang; Jian-Ju Liu; Li Dong; Zhuo-Lei Feng
Journal:  Mol Biol Rep       Date:  2008-12-24       Impact factor: 2.316

7.  Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study.

Authors:  Lukas J A G Ricker; Aize Kijlstra; Alfons G H Kessels; Wilco de Jager; Albert T A Liem; Fred Hendrikse; Ellen C La Heij
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

8.  Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.

Authors:  Dawid G Nowak; Elianna Mohamed Amin; Emma S Rennel; Coralie Hoareau-Aveilla; Melissa Gammons; Gopinath Damodoran; Masatoshi Hagiwara; Steven J Harper; Jeanette Woolard; Michael R Ladomery; David O Bates
Journal:  J Biol Chem       Date:  2009-11-11       Impact factor: 5.157

9.  Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells.

Authors:  Jing Ai; Yao Liu; Jun-Hui Sun
Journal:  Mol Med Rep       Date:  2012-10-24       Impact factor: 2.952

Review 10.  Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside.

Authors:  Stavros N Moysidis; Aristomenis Thanos; Demetrios G Vavvas
Journal:  Mediators Inflamm       Date:  2012-09-25       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.